Angiotensin-converting enzyme inhibitors (ACEi) have been involved in drug-induced pancreatitis previously, suggesting that this pathway can be involved in pancreas damage (Rouette et al, 2022; Twohig et al, 2021). The gene discussed is ACE; the disease is pancreatitis.